Resultados de la búsqueda 231-240 of 15394 for palliative care
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are ...
The five year follow-up period will ensure robust survival data for correlations with clinical, tumor, and treatment variables. The target of 2,500 patients is ...
... care, and your mental well-being before and after transplant. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy. Rochester, Minn ...
Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...
Rochester, Minn. This study is designed to: -analyze effects of surgical treatment -improve surgical care and quality of life of patients with hip problems/ ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Chemotherapy for the Treatment of Patients ...
Evaluaciones en el mismo día para enfermedades agudas; Medicina del deporte; Consultas de control pediátrico; Salud femenina; Enfermedad aguda en jóvenes ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?